XERIS BIOPHARMA HOLDINGS, INC. (XERS) Operating margin 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) operating margin by fiscal year — reported operating income divided by reported revenue.
8.5%FY2025 · since FY2020: -414.5% → 8.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.5% | +25.1 pp |
| FY2024 | -16.6% | +10.3 pp |
| FY2023 | -26.8% | +47.5 pp |
| FY2022 | -74.3% | +157.9 pp |
| FY2021 | -232.2% | +182.3 pp |
| FY2020 | -414.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice